Market Overview:
The global artificial tears market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of dry eye syndrome, rising awareness about the benefits of artificial tears, and technological advancements in the field of artificial tears products. The global artificial tears market is segmented on the basis of type, application, and region. On the basis of type, it is divided into two segments: artificial tear liquid and artificial tear ointment. The liquid segment dominates this market owing to its easy availability and low cost as compared to ointments. However, ointments are preferred by patients with severe cases of dry eyes as they provide long-lasting relief from symptoms associated with dry eyes syndrome. On the basis of application, it is further divided into three segments: dry eyes treatment, contact lenses moisten (CLMs), and others (such as wound care). Dry eyes treatment accounts for a major share in this market due to high incidence rateofdry eye syndrome across all regions worldwide.
Product Definition:
Artificial tears are a type of eye drops used to relieve dry eyes. They work by adding moisture to the eyes, which can help improve vision and make it more comfortable to keep your eyes open.
Artificial Tear Liquid:
Artificial tear liquid is a solution that helps in maintaining the lubrication of eye surface. It also provides relief to it by reducing dryness and irritation caused due to dust, pollution, chemicals or other irritants that can enter the eye. The artificial tear liquid market is driven by factors such as increasing prevalence of ocular disorders like dry eyes among others and growing demand for efficient products with improved safety & efficacy.
Artificial Tear Ointment:
Artificial tear ointment is a topical solution that helps in lubricating and healing dry eye surfaces. It also provides temporary relief from burning, stinging, or itching sensation caused by dry eye conditions. The ointment contains artificial tears that are formulated to have the same properties as natural tears and thus provide similar benefits for treating dry eyes.
Application Insights:
Based on the application, the market is segmented into dry eyes treatment, contact lenses moisten, others and others. The contact lens moisten application segment held the largest share in 2017 due to increasing use of artificial tear ointments by optometrists for cleaning and moisturizing of eyes. Optometrists usually recommend a course of three to six months for effective dry eye treatment.
The other applications include indications related to redness or irritation of eyelids caused by various factors such as allergies or environmental pollution. Artificial tears are also used in various other indications such as corneal healing after puncture injury, post-surgical inflammation reduction and prevention from further damage caused due to mechanical trauma or chemical burns on eye tissue layers leading to edema formation around cornea resulting in pain & discomfort along with visual impairment at times requiring medical attention which is driving growth over other segments globally.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities and product launches by prominent players operating in this region. For instance, Bausch & Lomb launched a new tear-free artificial tears called Preservative Free Artificial Tears (PFAT) for dry eye patients in 2018. Asia Pacific is expected to grow at a significant rate over the forecast period owing to rising disposable income levels resulting into increased adoption of various treatment options for Dry Eye Disease (DED). In addition, growing medical tourism industry due to availability of advanced treatments at low cost will also boost demand for artificial tears in Asia Pacific region over next eight years.
Growth Factors:
- Increasing prevalence of dry eye syndrome (DES)
- Growing awareness about the benefits of artificial tears over other treatment options for DES
- Rising demand for artificial tears from emerging markets
- Technological advancements in the manufacturing of artificial tears products
- increasing number of product launches by key players
Scope Of The Report
Report Attributes
Report Details
Report Title
Artificial Tears Market Research Report
By Type
Artificial Tear Liquid, Artificial Tear Ointment
By Application
Dry Eyes Treatment, Contact Lenses Moisten, Others
By Companies
Allergan, Alcon (Novartis), Bausch & Lomb, Abbott, Santen Pharmaceutical, Ursapharm, Rohto, Similasan Corporation, Johnson & Johnson, Ocusoft, Nicox, Sintong, Wuhan Yuanda
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Artificial Tears Market Report Segments:
The global Artificial Tears market is segmented on the basis of:
Types
Artificial Tear Liquid, Artificial Tear Ointment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dry Eyes Treatment, Contact Lenses Moisten, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Alcon (Novartis)
- Bausch & Lomb
- Abbott
- Santen Pharmaceutical
- Ursapharm
- Rohto
- Similasan Corporation
- Johnson & Johnson
- Ocusoft
- Nicox
- Sintong
- Wuhan Yuanda
Highlights of The Artificial Tears Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Artificial Tear Liquid
- Artificial Tear Ointment
- By Application:
- Dry Eyes Treatment
- Contact Lenses Moisten
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Artificial Tears Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Artificial Tears are a type of medication that help people with dry eyes. They are made from chemicals and water, and they flow through the eye to keep it moist.
Some of the major players in the artificial tears market are Allergan, Alcon (Novartis), Bausch & Lomb, Abbott, Santen Pharmaceutical, Ursapharm, Rohto, Similasan Corporation, Johnson & Johnson, Ocusoft, Nicox, Sintong, Wuhan Yuanda.
The artificial tears market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Tears Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Artificial Tears Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Artificial Tears Market - Supply Chain
4.5. Global Artificial Tears Market Forecast
4.5.1. Artificial Tears Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Artificial Tears Market Size (000 Units) and Y-o-Y Growth
4.5.3. Artificial Tears Market Absolute $ Opportunity
5. Global Artificial Tears Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Artificial Tears Market Size and Volume Forecast by Type
5.3.1. Artificial Tear Liquid
5.3.2. Artificial Tear Ointment
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Artificial Tears Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Artificial Tears Market Size and Volume Forecast by Application
6.3.1. Dry Eyes Treatment
6.3.2. Contact Lenses Moisten
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Artificial Tears Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Artificial Tears Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Artificial Tears Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Artificial Tears Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Artificial Tears Demand Share Forecast, 2019-2026
9. North America Artificial Tears Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Artificial Tears Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Artificial Tears Market Size and Volume Forecast by Application
9.4.1. Dry Eyes Treatment
9.4.2. Contact Lenses Moisten
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Artificial Tears Market Size and Volume Forecast by Type
9.7.1. Artificial Tear Liquid
9.7.2. Artificial Tear Ointment
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Artificial Tears Demand Share Forecast, 2019-2026
10. Latin America Artificial Tears Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Artificial Tears Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Artificial Tears Market Size and Volume Forecast by Application
10.4.1. Dry Eyes Treatment
10.4.2. Contact Lenses Moisten
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Artificial Tears Market Size and Volume Forecast by Type
10.7.1. Artificial Tear Liquid
10.7.2. Artificial Tear Ointment
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Artificial Tears Demand Share Forecast, 2019-2026
11. Europe Artificial Tears Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Artificial Tears Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Artificial Tears Market Size and Volume Forecast by Application
11.4.1. Dry Eyes Treatment
11.4.2. Contact Lenses Moisten
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Artificial Tears Market Size and Volume Forecast by Type
11.7.1. Artificial Tear Liquid
11.7.2. Artificial Tear Ointment
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Maket Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Artificial Tears Demand Share, 2019-2026
12. Asia Pacific Artificial Tears Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Artificial Tears Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Artificial Tears Market Size and Volume Forecast by Application
12.4.1. Dry Eyes Treatment
12.4.2. Contact Lenses Moisten
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Artificial Tears Market Size and Volume Forecast by Type
12.7.1. Artificial Tear Liquid
12.7.2. Artificial Tear Ointment
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Artificial Tears Demand Share, 2019-2026
13. Middle East & Africa Artificial Tears Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Artificial Tears Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Artificial Tears Market Size and Volume Forecast by Application
13.4.1. Dry Eyes Treatment
13.4.2. Contact Lenses Moisten
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Artificial Tears Market Size and Volume Forecast by Type
13.7.1. Artificial Tear Liquid
13.7.2. Artificial Tear Ointment
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Artificial Tears Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Artificial Tears Market: Market Share Analysis
14.2. Artificial Tears Distributors and Customers
14.3. Artificial Tears Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alcon (Novartis)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bausch & Lomb
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Santen Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ursapharm
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Rohto
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Similasan Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Johnson & Johnson
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Ocusoft
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Nicox
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Sintong
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Wuhan Yuanda
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
